Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objective. This study was designed to assess the effects of corticosteroids on select aspects of nervous system functioning, specifically, cognition and mood, as well as disease–related symptoms in individual patients with mild systemic lupus erythematosus (SLE) and mild neuropsychiatric (NP) symptoms. Methods. Ten women who had not been taking corticosteroids for at least 6 months were selected from a referral–based lupus clinic to participate in an N of 1 double–blind, controlled trial consisting of 3 randomly assigned drug/placebo pairings, with a drug dose of 0.5 mg/kg of prednisone daily. Results. Analysis of variance on the group data yielded significant positive drug effects for cognition (P = 0.02), mood (P = 0.003), and SLE symptom ratings (P = 0.0002). Drug efficacy was also evaluated by an objective decision rule, which yielded evidence of overall drug benefit in 5 of the 8 patients who completed the trial, and a deleterious drug effect in 1 patient. Posttrial clinical results indicated that for the 8 women who completed the trial, “acceptable” decisions, leading to remission of SLE symptoms or appropriate withholding of steroids, were made on the basis of this rule. Conclusion. Improvement in cognition, mood, and/or SLE symptom ratings can be observed following brief exposure to relatively low doses of corticosteroids in individual women with mild SLE; these persist over repeated drug exposure. The current application of N of 1 methodology represents the first systematic study of steroid efficacy in central nervous system (CNS)—related problems in SLE. The results can now be applied to the design of randomized, controlled trials of the effects of corticosteroids on CNS function in SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Chung, I. Y., & Benveniste, E. N. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.2999 · Cited by 609
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Reversible steroid dementia in patients without steroid psychosis
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.3.369 · Cited by 194
Long, A. A., Ginsberg, J. S., Brill-Edwards, P., Johnston, M., Turner, C., Denburg, J. A., Bensen, W. G., Cividino, A., Andrew, M., & Hirsh, J. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646452 · Cited by 120
Self-citation
Cited by
McEwen, B. S., & Sapolsky, R. M. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80028-x · Cited by 1,889
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Side Effects of Corticosteroid Therapy
Buchman, A. L. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200110000-00006 · Cited by 745
Bertsias, G. K., Ioannidis, J. P. A., Aringer, M., Bollen, E., Bombardieri, S., Bruce, I. N., Cervera, R., Dalakas, M., Doria, A., Hanly, J. G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130476 · Cited by 742
“Glucocorticoids and/or immunosuppressive therapy may be considered to control concurrent SLE or other NPSLE activity.”
BackgroundHanly, J. G., Urowitz, M. B., Su, L., Bae, S. C., Gordon, C., Wallace, D. J., Clarke, A., Bernatsky, S., Isenberg, D., Rahman, A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.106351 · Cited by 311
Psychiatric complications of treatment with corticosteroids: Review with case report
Kenna, H. A., Poon, A. W., de los Angeles, C. P., & Koran, L. M. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02260.x · Cited by 291
Diagnosis and management of neuropsychiatric SLE
Hanly, J. G. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.15 · Cited by 290
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations
Bertsias, G. K., & Boumpas, D. T. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.62 · Cited by 284
Kozora, E., Ellison, M. C., & West, S. (2006) · Arthritis Care & Research · doi:10.1002/art.22101 · Cited by 179
Corticosteroids and cognition: a meta-analysis
Prado, C. E., & Crowe, S. F. (2019) · Neuropsychology Review · doi:10.1007/s11065-019-09405-8 · Cited by 58
“However, other researchers have also reported non-significant effects, or even positive effects, across similar time frames (Denburg, Carbotte, & Denburg, 1994; Henckens, van Wingen, Joëls, & Fernández, 2011).”
Background
Metadata
- Authors
- Denburg, S. D., Carbotte, R. M., & Denburg, J. A.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1994-08
- Volume
- 37
- Issue
- 9
- Pages
- 1311-1320
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2034456061
- Cited by
- 145
- References
- 5
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.